Myriad Genetics (MYGN) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts MYGN Hot Sheet
Price: $5.88 +8.29%
Revenue Growth %: -2.7%
Financial Fact:
Companion diagnostic services: 12.4M
Today's EPS Names:
CGEH, NAKA, APOG, More
Revenue Growth %: -2.7%
Financial Fact:
Companion diagnostic services: 12.4M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
Myriad Genetics (NASDAQ: MYGN) reported Q3 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $191.9 million versus the consensus estimate of $179.23 million.
For earnings history and earnings-related data on Myriad Genetics (MYGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Benchmark Reiterates Buy Rating on IMAX Corporation (IMAX), Highlights 'The Odyssey' Potential
- Darden Restaurants (DRI) PT Raised to $240 at UBS as Stock Remains a 'Quality Compounder'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
